Skip to main content

Policy Issues in the Development of Personalized Medicine in Oncology Workshop Summary (2010) / Chapter Skim
Currently Skimming:

Summary
Pages 63-64

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 63...
... It also needs to develop superior methods of predictive test validation, improve test reliability, and advance how predictive tests are used in clinical decision making. In addition, methods for codeveloping biomarkers concurrently with targeted drugs need improvement.
Read the entire page →
From page 64...
... An IOM committee will examine these issues further, and develop consensus-based recommendations for moving the field of personalized medicine forward.
Read the entire page →

Key Terms

  • predictive test
  • improve test
  • including technological
  • tive tests
  • clinical decision

  • personalized cancer
  • cancer medicine
  • superior methods
  • develop superior
  • genetic pathways

  • tests work
  • test reliability
  • test validation
  • personalized medicine
  • developing predictive

  • participants expressed
  • workshop participants
  • participants suggested
  • participants noted
  • dictive tests

  • codeveloping biomarkers
  • reimbursement hurdles
  • biomarkers concurrently
  • rapid changes
  • expressed concern

  • targeted drugs
  • research community
  • biomarker development
  • iom committee


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.